Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Direct immobilization of manganese chelates on silica nanospheres for MRI applications.

Pálmai M, Pethő A, Nagy LN, Klébert S, May Z, Mihály J, Wacha A, Jemnitz K, Veres Z, Horváth I, Szigeti K, Máthé D, Varga Z.

J Colloid Interface Sci. 2017 Jul 15;498:298-305. doi: 10.1016/j.jcis.2017.03.053. Epub 2017 Mar 14.

PMID:
28343127
2.

Multifunctional mesoporous silica nanospheres with cleavable Gd(III) chelates as MRI contrast agents: synthesis, characterization, target-specificity, and renal clearance.

Vivero-Escoto JL, Taylor-Pashow KM, Huxford RC, Della Rocca J, Okoruwa C, An H, Lin W, Lin W.

Small. 2011 Dec 16;7(24):3519-28. doi: 10.1002/smll.201100521. Epub 2011 Nov 9.

3.

Mesoporous silica nanospheres as highly efficient MRI contrast agents.

Taylor KM, Kim JS, Rieter WJ, An H, Lin W, Lin W.

J Am Chem Soc. 2008 Feb 20;130(7):2154-5. doi: 10.1021/ja710193c. Epub 2008 Jan 25. No abstract available.

PMID:
18217764
4.

Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.

Li X, Zhao W, Liu X, Chen K, Zhu S, Shi P, Chen Y, Shi J.

Acta Biomater. 2016 Jan;30:378-387. doi: 10.1016/j.actbio.2015.11.036. Epub 2015 Nov 18.

PMID:
26602820
5.

Manganese-loaded dual-mesoporous silica spheres for efficient T1- and T2-weighted dual mode magnetic resonance imaging.

Niu D, Luo X, Li Y, Liu X, Wang X, Shi J.

ACS Appl Mater Interfaces. 2013 Oct 23;5(20):9942-8. doi: 10.1021/am401856w. Epub 2013 Oct 4.

PMID:
24059807
6.

Mn(2+)-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI.

Kim SM, Im GH, Lee DG, Lee JH, Lee WJ, Lee IS.

Biomaterials. 2013 Nov;34(35):8941-8. doi: 10.1016/j.biomaterials.2013.08.009. Epub 2013 Aug 21.

PMID:
23973173
7.

Synthesis and Evaluation of Manganese(II)-Based Ethylenediaminetetraacetic Acid-Ethoxybenzyl Conjugate as a Highly Stable Hepatobiliary Magnetic Resonance Imaging Contrast Agent.

Islam MK, Kim S, Kim HK, Kim YH, Lee YM, Choi G, Baek AR, Sung BK, Kim M, Cho AE, Kang H, Lee GH, Choi SH, Lee T, Park JA, Chang Y.

Bioconjug Chem. 2018 Nov 21;29(11):3614-3625. doi: 10.1021/acs.bioconjchem.8b00560. Epub 2018 Nov 6.

PMID:
30383368
8.

Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.

Guillet-Nicolas R, Laprise-Pelletier M, Nair MM, Chevallier P, Lagueux J, Gossuin Y, Laurent S, Kleitz F, Fortin MA.

Nanoscale. 2013 Dec 7;5(23):11499-511. doi: 10.1039/c3nr02969g. Epub 2013 Oct 31.

PMID:
24178890
9.

An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix.

Tan M, Wu X, Jeong EK, Chen Q, Parker DL, Lu ZR.

Mol Pharm. 2010 Aug 2;7(4):936-43. doi: 10.1021/mp100054m.

10.

T1-T2 molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents.

Li J, You J, Wu C, Dai Y, Shi M, Dong L, Xu K.

Int J Nanomedicine. 2018 Aug 10;13:4607-4625. doi: 10.2147/IJN.S168660. eCollection 2018.

11.

Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres.

Shen D, Yang J, Li X, Zhou L, Zhang R, Li W, Chen L, Wang R, Zhang F, Zhao D.

Nano Lett. 2014 Feb 12;14(2):923-32. doi: 10.1021/nl404316v. Epub 2014 Jan 31.

PMID:
24467566
12.

Paramagnetic hollow silica nanospheres for in vivo targeted ultrasound and magnetic resonance imaging.

An L, Hu H, Du J, Wei J, Wang L, Yang H, Wu D, Shi H, Li F, Yang S.

Biomaterials. 2014 Jul;35(20):5381-5392. doi: 10.1016/j.biomaterials.2014.03.030. Epub 2014 Apr 3.

PMID:
24703718
13.

Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.

Unger EC, Shen D, Wu G, Stewart L, Matsunaga TO, Trouard TP.

MAGMA. 1999 Aug;8(3):154-62.

PMID:
10504042
14.

Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents.

Ratzinger G, Agrawal P, Körner W, Lonkai J, Sanders HM, Terreno E, Wirth M, Strijkers GJ, Nicolay K, Gabor F.

Biomaterials. 2010 Nov;31(33):8716-23. doi: 10.1016/j.biomaterials.2010.07.095. Epub 2010 Aug 24.

PMID:
20797782
15.

Mn(II)-monosubstituted polyoxometalates as candidates for contrast agents in magnetic resonance imaging.

Li Z, Li W, Li X, Pei F, Wang X, Lei H.

J Inorg Biochem. 2007 Jul;101(7):1036-42. Epub 2007 Apr 19.

PMID:
17524483
16.

Manganese Complex of Ethylenediaminetetraacetic Acid (EDTA)-Benzothiazole Aniline (BTA) Conjugate as a Potential Liver-Targeting MRI Contrast Agent.

Islam MK, Kim S, Kim HK, Park S, Lee GH, Kang HJ, Jung JC, Park JS, Kim TJ, Chang Y.

J Med Chem. 2017 Apr 13;60(7):2993-3001. doi: 10.1021/acs.jmedchem.6b01799. Epub 2017 Mar 22.

PMID:
28301142
17.

Bioinspired, Manganese-Chelated Alginate-Polydopamine Nanomaterials for Efficient in Vivo T1-Weighted Magnetic Resonance Imaging.

Addisu KD, Hailemeskel BZ, Mekuria SL, Andrgie AT, Lin YC, Tsai HC.

ACS Appl Mater Interfaces. 2018 Feb 14;10(6):5147-5160. doi: 10.1021/acsami.7b13396. Epub 2018 Feb 5.

PMID:
29277987
18.

Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents.

Tan M, Ye Z, Jeong EK, Wu X, Parker DL, Lu ZR.

Bioconjug Chem. 2011 May 18;22(5):931-7. doi: 10.1021/bc100573t. Epub 2011 Apr 19.

19.

Construction and characterization of a theranostic system based on graphene/manganese chelate.

Karimi Shervedani R, Samiei Foroushani M, Kefayat A, Torabi M, Rahnemaye Rahsepar F.

Biosens Bioelectron. 2018 Oct 15;117:794-801. doi: 10.1016/j.bios.2018.07.011. Epub 2018 Jul 10.

PMID:
30096733
20.

Magnetic-sensitive silica nanospheres for controlled drug release.

Hu SH, Liu TY, Huang HY, Liu DM, Chen SY.

Langmuir. 2008 Jan 1;24(1):239-44. Epub 2007 Dec 1.

PMID:
18052081

Supplemental Content

Support Center